Inducible activation of oncogenic K-ras results in tumor formation in the oral cavityCAULIN, Carlos; NGUYEN, Thao; LONGLEY, Mary A et al.Cancer research (Baltimore). 2004, Vol 64, Num 15, pp 5054-5058, issn 0008-5472, 5 p.Article

Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient = Activation maligne d'un oncogène K-ras dans le cancer du poumon mais pas dans le tissu normal du même maladeSANTOS, E; MARTIN-ZANCA, D; PREMKUMAR REDDY, E et al.Science (Washington, D.C.). 1984, Vol 223, Num 4637, pp 661-664, issn 0036-8075Article

Deficiencies in mouse Myh and Ogg1 result in tumor predisposition and G to T mutations in codon 12 of the K-ras oncogene in lung tumorsYALI XIE; HANJING YANG; MILLER, Jeffrey H et al.Cancer research (Baltimore). 2004, Vol 64, Num 9, pp 3096-3102, issn 0008-5472, 7 p.Article

Valeur pronostique des mutations du gène K-RAS dans le cancer colorectal = Prognostic value of K-RAS mutation in colorectal cancerCEROTTINI, J. P; GIVEL, J. C; BENHATTAR, J et al.Swiss surgery. 1995, Num 6, pp 304-306, issn 1023-9332Article

STAT3 Plays a Critical Role in KRAS-Induced Pancreatic TumorigenesisCORCORAN, Ryan B; CONTINO, Gianmarco; DESHPANDE, Vikram et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 14, pp 5020-5029, issn 0008-5472, 10 p.Article

Rapid and sensitive nonradioactive detection of mutant K-ras genes via «enriched» PCR amplificationKAHN, S. M; WEI JIANG; CULBERTSON, T. A et al.Oncogene : (Basingstoke). 1991, Vol 6, Num 6, pp 1079-1083Article

KRAS Mutation: Should We Test for It, and Does It Matter?ROBERTS, Patrick J; STINCHCOMBE, Thomas E.Journal of clinical oncology. 2013, Vol 31, Num 8, pp 1112-1120, issn 0732-183X, 9 p.Article

Oncogenic Kras Promotes Chemotherapy-Induced Growth Factor Shedding via ADAM17VAN SCHAEYBROECK, Sandra; KYULA, Joan N; FENTON, Audrey et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 3, pp 1071-1080, issn 0008-5472, 10 p.Article

Expansion of the genotypic and phenotypic spectrum in patients with KRAS germline mutationsZENKER, Martin; LEHMANN, Katarina; MUNDLOS, Stefan et al.Journal of medical genetics. 2007, Vol 44, Num 2, pp 131-135, issn 0022-2593, 5 p.Article

Etudes structurales par RMN d'oligonucléotides contenant soit une paire de bases non complémentaires soit une lacune d'un nucléotide = NMR structural studies of oligonucleotides containing non complementary bases pairs or a one nucleotide gapFaibis, Valérie; Fazakerley, V.1996, 151 p.Thesis

Tissue-specific hypomethylation of the human c-K-ras geneMETTER, J; CHONG CHO.Nucleic acids research. 1989, Vol 17, Num 17, pp 7089-7099, issn 0305-1048Article

Somatic activation of ras^K gene in a human ovarian carcinoma = Activation somatique du gène rasK dans un cancer de l'ovaire humainFEIG, L. A; BAST, R. C. JR; KNAPP, R. C et al.Science (Washington, D.C.). 1984, Vol 223, Num 4637, pp 698-701, issn 0036-8075Article

A cell line from a human ovarian carcinoma with amplification of the K-ras geneFILMUS, J; TRENT, J. M; PULLANO, R et al.Cancer research (Baltimore). 1986, Vol 46, Num 10, pp 5179-5182, issn 0008-5472Article

4-Hydroxytamoxifen Induces Autophagic Death through K-Ras DegradationKOHLI, Latika; KAZA, Niroop; CORIC, Tatjana et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 14, pp 4395-4405, issn 0008-5472, 11 p.Article

KRAS mutations in historical tumour specimens of the Viennese Museum of pathological anatomySEDIVY, Roland; KALIPCIYAN, Maria; PATZAK, Beatrix et al.Histopathology. 2011, Vol 58, Num 5, pp 792-796, issn 0309-0167, 5 p.Article

Ras and myelodysplasia : Lessons from the last decadePARKER, J; MUFTI, G. J.Seminars in hematology. 1996, Vol 33, Num 3, pp 206-224, issn 0037-1963Article

K-Ras and H-Ras activation promote distinct consequences on endometrial cell survivalNINOMIYA, Yumiko; KATO, Kiyoko; TAKAHASHI, Akira et al.Cancer research (Baltimore). 2004, Vol 64, Num 8, pp 2759-2765, issn 0008-5472, 7 p.Article

H- and K-ras mutational profiles in chemically induced liver tumors from B6C3F₁ and CD-1 miceMANJANATHA, M. G; LI, E. E; FU, P. P et al.Journal of toxicology and environmental health. 1996, Vol 47, Num 2, pp 195-208, issn 0098-4108Article

mTOR activation in medullary thyroid carcinoma with RAS mutationLYRA, Joana; VINAGRE, João; BATISTA, Rui et al.European journal of endocrinology. 2014, Vol 171, Num 5, pp 633-640, issn 0804-4643, 8 p.Article

Searching for Solutions in Aquaculture: Charting a Sustainable CourseKLINGER, Dane; NAYLOR, Rosamond.Annual review of environment and resources. 2012, Vol 37, pp 247-276, issn 1543-5938, 30 p.Article

Prevalence of RAS point mutations in papillary thyroid Carcinoma; A novel mutation at codon 31 of K-RASCYNIAK-MAGIERSKA, A; BRZEZIARISKA, E; JANUSZKIEWICZ -CAULIER, J et al.Experimental and clinical endocrinology & diabetes. 2007, Vol 115, Num 9, pp 594-599, issn 0947-7349, 6 p.Article

Reduced MGMT activity in human colorectal adenomas is associated with K-ras GC→AT transition mutations in a population exposed to methylating agentsLEES, Nicholas P; HARRISON, Kathryn L; HALL, C. Nick et al.Carcinogenesis (New York. Print). 2004, Vol 25, Num 7, pp 1243-1247, issn 0143-3334, 5 p.Article

High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascadeKIESSLING, Michael K; OBERHOLZER, Patrick A; FRENCH, Lars E et al.Blood. 2011, Vol 117, Num 8, pp 2433-2440, issn 0006-4971, 8 p.Article

Somatic KRAS mutations associated with a human nonmalignant syndrome of autoimmunity and abnormal leukocyte homeostasisNIEMELA, Julie E; LIANGHAO LU; KONETI RAO, V et al.Blood. 2011, Vol 117, Num 10, pp 2883-2886, issn 0006-4971, 4 p.Article

Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor CellsYUN, Jihye; RAGO, Carlo; DIAZ, Luis A et al.Science (Washington, D.C.). 2009, Vol 325, Num 5947, pp 1555-1559, issn 0036-8075, 5 p.Article